Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
5.47
+0.02 (0.46%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Vir Biotechnology Employees
Vir Biotechnology had 408 employees as of December 31, 2024. The number of employees decreased by 179 or -30.49% compared to the previous year.
Employees
408
Change (1Y)
-179
Growth (1Y)
-30.49%
Revenue / Employee
$181,875
Profits / Employee
-$1,279,314
Market Cap
754.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
VIR News
- 4 weeks ago - Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results - PRNewsWire
- 5 weeks ago - Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta - Business Wire
- 7 weeks ago - Vir Biotechnology, Inc. (VIR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 2 months ago - Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference - Business Wire
- 2 months ago - Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Business Wire
- 3 months ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
- 3 months ago - Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why - Benzinga